- Report
- September 2020
- 110 Pages
Global
From €1319EUR$1,375USD£1,141GBP
€2639EUR$2,750USD£2,282GBP
- Report
- April 2020
- 82 Pages
Global
From €1319EUR$1,375USD£1,141GBP
€2639EUR$2,750USD£2,282GBP
€2874EUR$2,995USD£2,485GBP
- Report
- February 2019
- 156 Pages
Global
From €2878EUR$3,000USD£2,489GBP
- Report
- November 2018
- 11 Pages
Europe
From €2874EUR$2,995USD£2,485GBP
- Report
- November 2018
- 125 Pages
Europe
From €2878EUR$3,000USD£2,489GBP
The Health Technology Assessment (HTA) market within the context of Pharmaceuticals is a rapidly growing industry. It is a process of evaluating the clinical, economic, and social impact of a medical technology, such as a drug, device, or procedure. HTA is used to inform decision-making in healthcare, such as reimbursement decisions, and to ensure that healthcare resources are used in the most effective and efficient way. HTA is conducted by independent organizations, such as government agencies, research institutes, and private companies.
HTA is becoming increasingly important in the pharmaceutical industry, as it helps to ensure that new drugs are safe and effective, and that they provide value for money. HTA also helps to ensure that new drugs are used appropriately, and that they are targeted to the right patients.
Some companies in the HTA market include IQVIA, Parexel, Syneos Health, and Evidera. Show Less Read more